Do you have questions?

We have answers

What is Semaglutide and Tirzepatide?

Semaglutide is a GLP-1 receptor agonist that supports weight management by mimicking the natural hormone GLP-1. It helps regulate appetite and insulin secretion, reducing hunger and improving blood sugar control, which can lead to weight loss.

Tirzepatide works on both GLP-1 and GIP receptors, offering a dual-action approach. This means it not only helps curb appetite and control blood sugar but also supports overall metabolic health, making it effective for weight management and glycemic control.
Both medications offer innovative solutions for individuals seeking help with weight loss and metabolic balance. For personalized advice, please consult your healthcare provider.

Yes. Semaglutide, the drug used in Wegovy and Ozempic, and Tirzepatide, the active ingredient in Mounjaro and Zepbound, have been shown to support weight loss and long-term weight management in multiple studies.

It’s important to disclose your medical history including pre-existing medical conditions. Our healthcare professionals will evaluate your health status and provide guidance on whether Semaglutide is a suitable option given your pre-existing conditions.

Actual weight lost is dependent on a number of factors but in average patients lose around 10% of their initial body weight in the first 12 weeks. This equates to a weight loss of 10–20 pounds for a 200-pound person. Everyone is different though, and the most successful patients also work hard to make diet and lifestyle changes.

This program will help you lose unwanted weight and put your body in weight-loss mode. Some patients continue for over six months depending on the amount of weight they want to lose. Your team will create a maintenance plan for you once you reach your goal weight, but like everything else in life, it’s up to you. Most patients adopt a healthier lifestyle as they start shedding weight because they feel good and want to continue the new habits they have adopted.

 Side effects for GLP-1s may include nausea(most common), also but less likely: vomiting, stomach pain, upset stomach, dizziness, constipation, feeling bloated, belching, gas, headaches, and fatigue. If you do experience side effects, they usually subside after a few days of your body getting used to the medication. In the most recent clinical trials, less than 5% of people discontinued GLP-1 medications because of side effects.

Your membership includes a shipment every 90 days for Semaglutide and every 60 days for Tirzepatide, pending medical approval. If you prefer a month-to-month plan, you can opt for it at an additional cost of $100.

WholeHealthMD proudly provides telehealth services in the following states:
  • California
  • Florida
  • Texas
  • New York
  • Virginia
  • Illinois
If you reside in any of these states, you can access our comprehensive telehealth services for your weight loss and wellness needs.